Microchip CEO sells 416,581 shares in 10b5-1 plan

Microchip Technology President, CEO and Chair Steve Sanghi reported an open-market sale of 416,581 shares of Common Stock at $88.5329 per share under a pre-arranged Rule 10b5-1 trading plan.

Rhea-AI Filing Summary

Microchip Technology President, CEO and Chair Steve Sanghi reported an open-market sale of 416,581 shares of Common Stock at $88.5329 per share under a pre-arranged Rule 10b5-1 trading plan. After this indirect sale through a trust and a family limited partnership, he continues to hold 9,495,805 shares indirectly.

Insider Trade Summary 10b5-1

Net Seller: 416,581 shares

Net Sell 1 txn

Insider Sanghi Steve

Role President, CEO and Chair of Bd

Sold 416,581 shs ($36.88M)

Type	Security	Shares	Price	Value
Sale	Common Stock	416,581	$88.5329	$36.88M

Holdings After Transaction: Common Stock — 9,495,805 shares (Indirect, Shares held Indirectly, by Trust and by Family Limited Partnership.)

Footnotes (2)

1. F1. The sale(s) reported in this Form 4 was/were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025. Sanghi
2. F2. Of the 9,495,805 shares held, 3,589,933 shares were held by The Sanghi Trust; and 5,905,872 shares were held by The Sanghi Family Limited Partnership.

Key Figures

Shares sold: 416,581 shares Sale price per share: $88.5329 per share Shares held after transaction: 9,495,805 shares +2 more

5 metrics

Shares sold 416,581 shares Open-market sale on 2026-04-23

Sale price per share $88.5329 per share Price for 416,581 common shares sold

Shares held after transaction 9,495,805 shares Indirect ownership following the sale

Trust-held shares 3,589,933 shares Held by The Sanghi Trust as part of indirect holdings

Family partnership shares 5,905,872 shares Held by The Sanghi Family Limited Partnership

Key Terms

Rule 10b5-1 trading plan, Form 4, Family Limited Partnership, Common Stock, +1 more

5 terms

Rule 10b5-1 trading plan regulatory

"The sale(s) reported in this Form 4 was/were effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

Form 4 regulatory

"The sale(s) reported in this Form 4 was/were effected pursuant to a Rule 10b5-1 trading plan"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Family Limited Partnership financial

"5,905,872 shares were held by The Sanghi Family Limited Partnership."

Common Stock financial

"security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

indirect ownership financial

"Shares held Indirectly, by Trust and by Family Limited Partnership."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Microchip (MCHP) CEO Steve Sanghi report in this Form 4?

Steve Sanghi reported an open-market sale of 416,581 Microchip common shares. The transaction was executed at an average price of $88.5329 per share under a Rule 10b5-1 trading plan, as disclosed in the filing’s transaction details and footnotes.

Was the Microchip (MCHP) CEO’s share sale pre-planned under a Rule 10b5-1 plan?

Yes. The filing states the sales were effected under a Rule 10b5-1 trading plan adopted by the reporting person. Such plans pre-schedule trades, indicating the timing of this 416,581-share sale was set in advance rather than decided opportunistically.

How many Microchip (MCHP) shares did Steve Sanghi hold after the reported sale?

After the transaction, total holdings reported were 9,495,805 Microchip common shares. A footnote explains that 3,589,933 shares are held by The Sanghi Trust and 5,905,872 shares are held by The Sanghi Family Limited Partnership, both counted as indirect ownership.

At what price were the Microchip (MCHP) shares sold in this Form 4 filing?

The reported open-market sale occurred at an average price of $88.5329 per share. This price applies to the 416,581 Microchip common shares sold, according to the transaction line in the Form 4, which lists the per-share sale price explicitly.

Are the Microchip (MCHP) CEO’s reported holdings direct or indirect after the sale?

The Form 4 identifies the post-transaction ownership as indirect. It notes shares are held by The Sanghi Trust and The Sanghi Family Limited Partnership, with the ownership code marked as indirect, reflecting holdings through these related entities rather than directly.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/27/2026 - 04:42 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sanghi Steve

(Last) (First) (Middle)

C/O MICROCHIP TECHNOLOGY INCORPORATED

2355 WEST CHANDLER BOULEVARD

(Street)

CHANDLER ARIZONA 85224-6199

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MICROCHIP TECHNOLOGY INC [ MCHP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, CEO and Chair of Bd

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/23/2026		S(1)		416,581	D	$88.5329	9,495,805(2)	I	Shares held Indirectly, by Trust and by Family Limited Partnership.(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale(s) reported in this Form 4 was/were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025. Sanghi

2. Of the 9,495,805 shares held, 3,589,933 shares were held by The Sanghi Trust; and 5,905,872 shares were held by The Sanghi Family Limited Partnership.

Remarks:

	Deborah L. Wussler, as Attorney-in-Fact	04/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)